Product Reports Resources Pricing Login Book a demo

Everest Medicines

Biotech & Life Sciences · New York City, United States · Founded 2017 · IPO 2020

Everest Medicines was founded with a vision to address the critical need for innovative medicines in Asia. The company was co-founded by Wei Fu, who brought a wealth of experience from his previous roles in the pharmaceutical industry. Everest Medicines focuses on licensing, developing, and commercializing transformative pharmaceutical products that address critical unmet medical needs. The company has strategically partnered with global biopharmaceutical companies to bring cutting-edge therapies to the Asian market. This approach has allowed Everest Medicines to build a robust pipeline of promising drug candidates across oncology, immunology, cardio-renal, and infectious diseases. A significant milestone in Everest Medicines' journey was its successful IPO on the Hong Kong Stock Exchange in October 2020. This event marked a new chapter for the company, providing the necessary capital to accelerate its development programs and expand its commercial capabilities. Everest Medicines continues to leverage its strong partnerships and innovative pipeline to make a meaningful impact on patients' lives in Asia. The company's commitment to addressing unmet medical needs remains at the core of its mission, driving its growth and success in the biopharmaceutical industry.

Valuation $822M
Revenue $454M
EBITDA $76M
Total funding $100–500M
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue
Featured in
News CBC Group's $21B healthcare mega-merger lifts Everest Medicines bet Jun 3, 2026

Investors

6 investors on Everest Medicines's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
CBC Group
Cormorant Asset Management
HBM Healthcare Investments
Series B+ 3 investors entered at this stage
Janchor Partners
Hillhouse Capital
RA Capital Management

Global footprint

Where Everest Medicines has talent and traffic

Workforce by country
6 countries with
team presence
🇨🇳 China84.5%
🇺🇸 United States7.8%
🇸🇬 Singapore2.9%
🇹🇼 Taiwan1.9%
🇭🇰 Hong Kong1%
Top 5 of 6 shown
Web traffic by country
49K monthly visits
across markets
🇨🇳 China91.8%
🇺🇸 United States5.1%
🇭🇰 Hong Kong1.6%
🇮🇳 India1%
🇵🇭 Philippines0.2%
Top 5 markets shown

Talent graph

The shape of Everest Medicines's talent

Dealroom maps Everest Medicines's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

9 team members profilednamed & role-tagged by Dealroom
153 employeestotal headcount
2 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Everest Medicines's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$16M patent portfolio · 10 active families

Estimated portfolio value
$16M
2.0% of market cap · 9× smaller than top peer CureVac ($146M)
10 active patent families
Where Everest Medicines innovates AntigenCancer antigenCancer vaccineCarcinosisMolecular biology

Where Everest Medicines concentrates vs peers

Each axis is a top-10 topic across Everest Medicines and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Everest Medicines

An AI-synthesized read of the highest-engagement posts about Everest Medicines on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Everest Medicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles